Company: STAA
Filing Date: 2025-12-10
Form Type: DEFA14A
Source: 0001193125-25-314435
Chunk: 12

Company: STAAR SURGICAL CO
Filing Date: 2025-12-10
Form: DEFA14A
Chunk 12
---
, held discussions with members of STAAR’s management team, and carefully considered a number of factors that it believed supported its determination. These factors included the fact that (i) the Second Amendment increased the Merger Consideration payable to STAAR’s stockholders from $28.00 per share in cash to $30.75 per share in cash and (ii) no Acquisition Proposals were received by STAAR during the go-shop period that expired on December 6, 2025.

The foregoing discussion of factors considered by the Board is not intended to be exhaustive, but rather includes the material factors considered by the Board. In reaching its decision that the Merger Agreement and the transactions contemplated thereby, as amended by the Amendments, including the Merger, are advisable, fair to and in the best interests of STAAR and its stockholders, the Board did not

9

quantify, rank or otherwise assign any relative weights to, and did not make specific assessments of, the factors considered, and individual directors may have given different weights to different factors. The Board did not reach any specific conclusion with respect to any of the factors or reasons considered, but determined, in its business judgment, that, in the aggregate, the potential benefits it considered outweighed the potential risks or possible negative consequences of approving the Second Amendment.

The explanation of the factors and reasoning set forth above contain forward-looking statements and should be read in conjunction with the section of this proxy statement titled “Special Note Regarding Forward-Looking Statements.”

The last paragraph of the section titled “—Treatment of STAAR Long-Term Incentive Awards” on page 63 of the proxy statement is hereby amended and supplemented as follows:

For an estimate of the value of
unvested equity awards held by STAAR’s named executive officers that would vest assuming that the Merger occurs on August 27, 2025December 5, 2025, see “—Quantification of Payments and Benefits to STAAR’s Named Executive Officers” below. We estimate that the aggregate value of unvested equity awards held by all non-employee directors of STAAR that would vest assuming that the Merger occurs on
August 27, 2025December 5, 2025 is $2,553,676 $2,804,483, calculated based on the Merger Consideration of $28.00 $30.75 per share.

The second and third paragraphs of the section titled “—Change in Control Agreements” on page 64 of the proxy statement are